US industry embraces SUDs (single use devices) regulatory scheme
This article was originally published in Clinica
The US FDA's new regulatory scheme for reprocessing single use devices (SUDs) is proving to be a boon for third-party reprocessors. "The industry is thriving," Pamela Furman, executive director of the Association of Medical Device Reprocessors, told last week's annual meeting of the Regulatory Affairs Professionals Society in Baltimore, Maryland. "Reprocessing has come out of the closet, so to speak," she said.